Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA

Annals of Surgery

Volumn 230, Issue 4, 1999, Pages 466-472

  Rosengart, Todd K ^a   Lee, Leonard Y ^a   Patel, Shailen R ^a   Kligfield, Paul D ^a   Okin, Peter M ^a   Hackett, Neil R ^a   Isom, O Wayne ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VIRUS VECTOR;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; FEMALE; GENE THERAPY; HUMAN; HUMAN ADENOVIRUS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADENOVIRIDAE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CORONARY DISEASE; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033503798     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199910000-00002     Document Type: Conference Paper

References (19)

1. Rosengart TK, Patel SR, Crystal RG. Therapeutic angiogenesis: protein and gene therapy delivery strategies. J Cardiovasc Risk 1999; 8:29-40.
2. Simons M, Ware JA. Food for starving hearts. Nat Med 1996; 2:519-520.
3. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 1994; 28:1176-1179.
4. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996; 270:H1803-H1811
5. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991; 47:211-218.
6. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980; 288:551-556.
7. Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998; 115:168-176.
8. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 271:603-606.
9. Losordo DW, Vale PR. Symes JF. et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98:2800-2804.
10. Mack CA, Magovern CJ, Budenbender KT, et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 1998; 27:699-709.
11. Magovern CJ, Mack CA, Zhang J, et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg 1996; 62:425-434.
12. Muhlhauser J, Merrill MJ, Pili R, et al. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 1995; 77:1077-1086.
13. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998; 2:549-558.
14. Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999; 100:468-474.
15. Rosenfeld MA, Yoshimura K, Trapnell BC, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68:143-155.
16. Mack CA, Song WR, Carpenter H, et al. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum Gene Ther 1997; 8:99-109.
17. Harvey B-G, Hackett NR, El-Sawy T, et al. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J Virol 1999; 73:6729-6742.
18. Campeau L. Grading of angina pectoris [letter]. Circulation 1976; 54:522-523.
19. Okin PM, Kligfield P. Heart rate adjustment of ST segment depression and performance of the exercise electrocardiogram: a critical evaluation. J Am Coll Cardiol 1995; 25:1726-1735.